SOLYMBIC Trademark

Trademark Overview

On Tuesday, January 29, 2013, a trademark application was filed for SOLYMBIC with the United States Patent and Trademark Office. The USPTO has given the SOLYMBIC trademark a serial number of 85835774. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 8, 2016. This trademark is owned by Amgen Inc.. The SOLYMBIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hyperlipidemia
solymbic

General Information

Serial Number85835774
Word MarkSOLYMBIC
Filing DateTuesday, January 29, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 8, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hyperlipidemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 5, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Monday, February 8, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 8, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 16, 2015EXTENSION 3 GRANTED
Friday, May 15, 2015EXTENSION 3 FILED
Friday, May 15, 2015TEAS EXTENSION RECEIVED
Friday, January 30, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 29, 2015EXTENSION 2 GRANTED
Friday, December 5, 2014EXTENSION 2 FILED
Tuesday, January 27, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 5, 2014TEAS EXTENSION RECEIVED
Friday, June 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 11, 2014EXTENSION 1 GRANTED
Wednesday, June 11, 2014EXTENSION 1 FILED
Wednesday, June 11, 2014TEAS EXTENSION RECEIVED
Tuesday, January 7, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 10, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 10, 2013ASSIGNED TO LIE
Friday, September 27, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 17, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 16, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 16, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 14, 2013NOTIFICATION OF PRIORITY ACTION E-MAILED
Tuesday, May 14, 2013PRIORITY ACTION E-MAILED
Tuesday, May 14, 2013PRIORITY ACTION WRITTEN
Wednesday, May 8, 2013ASSIGNED TO EXAMINER
Tuesday, February 5, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 1, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

solymbic hyperlipidemia treatment preparations pharmaceutical